KyungDong Pharm Co., Ltd. is strengthening its circulatory system product lineup by launching ‘Kyungdong Lipigrel Tablet 100mg’, a peripheral artery disease treatment containing sarpogrelate hydrochloride 100mg, on November 1.
‘Kyungdong Lipigrel Tablet 100mg’ is an antithrombotic product.
‘Kyungdong Lipigrel Tablet 100mg’ is a product used for peripheral artery disease. It has a selective antagonistic effect and is effective in inhibiting platelet aggregation and vascular smooth muscle cell proliferation. It improves ischemic symptoms caused by peripheral artery disease by increasing blood flow in the patient’s arms and legs. It is a product that significantly improves intermittent claudication and ankle brachial index in patients with obstructive arteriosclerosis compared to aspirin. ‘Kyungdong Lipigrel Tablet 100mg’ is a product that expands the range of prescription options and improves the convenience of taking.
※ Product information
▶ Product name: Kyungdong Lipigrel Tablet 100mg
▶ Ingredient content: sarpogrelate hydrochloride 100㎎
▶ Efficacy: Improvement of ischemic symptoms such as ulcers, pain, and cold sensation caused by chronic arterial occlusion.
▶ Dosage: Adults: As sarpogrelate hydrochloride, take 100 mg orally three times a day after meals. (Lifigrel extended-release tablet 300mg = once a day)
▶ Insurance price: 455 won/tablet
▶ Packaging unit: 30 tablets, 100 tablets
▶ Remarks: Please refer to the product manual for other details such as precautions for use.